Tag: Antibiotics

  • Antibiotics and IBS: Complex Relationship

    Antibiotics and IBS: Complex Relationship

    Patients often get frustrated by doctors worrying about prescribing antibiotics. One of many reasons why doctors think twice before prescribing antibiotics is that the connection between antibiotic use and Irritable Bowel Syndrome (IBS) has emerged as a topic of growing interest. A large-scale case–control study involving 29,111 IBS patients and 135,172 controls offers new insights into this association.

    The Study: A Deeper Dive into Antibiotics and IBS

    Led by Staller et al. (2023), this study marks a significant step in understanding the potential link between antibiotic exposure and the later development of IBS. The researchers meticulously analysed data, focusing on antibiotic use more than a year before an IBS diagnosis.

    Key Findings: A Dose-Response Relationship

    • Increased IBS Risk with Antibiotic Use: The study found a significant association between any history of antibiotic exposure and a later diagnosis of IBS.
    • The More Antibiotics, the Higher the Risk: Notably, there was a dose–response relationship. Individuals with three or more historical antibiotic prescriptions faced a 2.36 to 3.36 times higher risk of being diagnosed with IBS.

    Tetracyclines: A Notable Culprit

    While all antibiotic classes were linked to IBS development, tetracyclines showed the highest association, hinting at a class-specific impact on gut health.

    Other Factors in the IBS Puzzle

    • GI Infection History: Interestingly, a personal history of GI infection up to a year prior to IBS diagnosis didn’t significantly change the odds of developing IBS.
    • The Role of Acute GI Infection: Acute GI infection could be the initial trigger, with antibiotic exposure providing a second hit that disrupts the microbiome and potentially leads to IBS.

    A Closer Look at the IBS Subtypes

    The high proportion of IBS with diarrhoea (57.7%) in this study does raise some questions about potential biases in the methodology, such as the selection of cases undergoing colonoscopy and biopsy.

    Psychological Factors and Healthcare Seeking Behaviour

    The absence of data on psychiatric illnesses and antidepressant medication use in this population is a gap, given the known association of mental health conditions with IBS. Additionally, the higher number of outpatient visits in the IBS group suggests that healthcare-seeking behaviour might influence the likelihood of receiving antibiotics.

    Broader Implications and Future Directions

    The increasing global misuse of antibiotics, coupled with the complexity of the gut microbiome influenced by diet, medications, and genetics, underscores the need for further research. Key questions remain: What specific changes in the microbiome lead to IBS? And can interventions like prebiotics, probiotics, or dietary changes offer protection?

    My Perspective

    One takeaway is clear: limiting unnecessary antibiotic prescriptions should be a top public health priority. Understanding and addressing the nuances of antibiotic use and its impact on gut health is crucial to improving gastrointestinal well-being.

    To a healthier gut and a wiser approach to antibiotics.

    Please help someone else by sharing this blog. 

    DR J HUGH COYNE
    MBBS BSc PGDip (with merit) MRCGP DRCOG DCH

    Dr Hugh Coyne is a GP and co-founder of Coyne Medical, a private preventive health clinic at 660 Fulham Road, London. He trained at Imperial College London and has been in practice for over twenty years, with a particular focus on cardiovascular risk, metabolic health, and exercise medicine. After qualifying as a GP he went on to train in sport and exercise medicine, bringing a distinctly practical approach to prevention and long-term health.

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    Book a Health Screening

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

    Read More Longevity & Healthspan Guides
  • Optimal Antibiotic Treatment for Children with Pneumonia: Why Shorter Duration Is Safer and More Effective

    Optimal Antibiotic Treatment for Children with Pneumonia: Why Shorter Duration Is Safer and More Effective

    As a parent, your child’s health and well-being are always your top priority. Although severe illnesses like community-acquired pneumonia (CAP) are not that common, finding the most effective and safe treatment is still crucial. A recent systematic review, based on 16 randomised clinical trials, has shed light on the optimal duration of antibiotic treatment for children with CAP. 

    Insights from a Recent Review

    The study’s primary objective was to compare the efficacy and safety of shorter-duration (≤5 days) versus longer-duration antibiotic treatments in children with CAP. The researchers conducted a thorough search across various databases to gather data from 16 randomised clinical trials involving 12,774 paediatric patients. All the participants were treated as outpatients with oral antibiotics.

    The analysis revealed that there were no substantial differences between shorter-duration and longer-duration antibiotics in terms of clinical cure, treatment failure, and relapse rates. This suggests that the duration of antibiotic therapy may not significantly impact your child’s overall recovery from CAP.

    Clinical Equivalence

    Shorter-duration antibiotics did not appreciably increase the risk of mortality or severe adverse events when compared to longer-duration antibiotics. This finding provides reassurance that opting for shorter courses of antibiotics is unlikely to compromise your child’s safety.

    The study indicated that shorter-duration antibiotics probably have little or no impact on the need for hospitalisation or the necessity to change antibiotics. This implies that choosing a shorter course of treatment is unlikely to result in a more severe illness requiring hospital care.

    Safety Considerations

    One of the key advantages of choosing shorter-duration antibiotics is a reduced risk of side effects. Prolonged antibiotic exposure can lead to adverse reactions, and by limiting the duration, we can minimise this risk.

    Overuse of antibiotics can contribute to the development of antibiotic-resistant bacteria, making infections harder to treat in the future. By opting for shorter courses of antibiotics when appropriate, we can help combat the growing concern of antibiotic resistance.

    Reducing Risks and Burden

    Shorter-duration antibiotic therapy also brings relief to parents by reducing the overall administration burden. Fewer days of medication mean less hassle for both you and your child.

    Positive Conclusions

    Based on the findings of this comprehensive systematic review, shorter-duration antibiotic therapy appears to be just as effective and safe as longer-duration treatment for children with community-acquired pneumonia.  Not only does this approach lead to similar patient outcomes, but it also reduces the risk of side effects, combats antibiotic resistance, and eases the burden on parents.

    Collaboration with Healthcare Providers

    As always, it is essential to follow your healthcare provider’s recommendations regarding your child’s treatment. If your child is diagnosed with pneumonia, have an open and informed discussion with their healthcare provider about the best course of action based on the severity of the illness and individual medical history. With the right care and attention, your child can recover from pneumonia and get back to being their happy and healthy selves.

    DR J HUGH COYNE
    MBBS BSc PGDip (with merit) MRCGP DRCOG DCH

    Dr Hugh Coyne is a GP and co-founder of Coyne Medical, a private preventive health clinic at 660 Fulham Road, London. He trained at Imperial College London and has been in practice for over twenty years, with a particular focus on cardiovascular risk, metabolic health, and exercise medicine. After qualifying as a GP he went on to train in sport and exercise medicine, bringing a distinctly practical approach to prevention and long-term health.

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    Book a Health Screening

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

    Read More Child Health Guides